You are here

vaccines

Takeda's Phase III Dengue Vaccine Results Bring Them "One Step Closer" to Stopping Tropical Disease

Takeda's Phase III Dengue Vaccine Results Bring Them "One Step Closer" to Stopping Tropical Disease

BioSpace

tropical diseases

Flag link:

Advaxis suffers another blow as FDA puts phase 3 on partial hold

Advaxis suffers another blow as FDA puts phase 3 on partial hold

Fierce Biotech

clinical trials

axalimogene filolisbac

cervical cancer

Flag link:

Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there's no connection

Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there's no connection

Fierce Pharma

government shutdown

Flag link:

JPM: Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons

JPM: Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons

Fierce Pharma

Flag link:

A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight

A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight

Fierce Biotech

type 1 diabetes

Flag link:

Sanofi and Merck Snag FDA Approval for a Six-Disease Combination Vaccine

Sanofi and Merck Snag FDA Approval for a Six-Disease Combination Vaccine

BioSpace

haemophilus influenza type b

Flag link:

Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine

Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine

CP Wire

pneumococcal disease

Flag link:

Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine

pneumococcal disease

Flag link:

GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'

GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'

Fierce Pharma

Flag link:

Why Novavax Is Up 60% in 2018

Why Novavax Is Up 60% in 2018

Motley Fool

Flag link:

GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report

GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report

Fierce Pharma

Flag link:

UT Researchers Discover Alzheimer's Vaccine, Hope To Test In Humans Soon

UT Researchers Discover Alzheimer's Vaccine, Hope To Test In Humans Soon

Forbes

Alzheimer's disease

University of Texas

Flag link:

Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year

Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year

Fierce Pharma

Flag link:

Boehringer backs $33M cancer vaccine play at Switzerland's AMAL Therapeutics

Boehringer backs $33M cancer vaccine play at Switzerland's AMAL Therapeutics

Endpoints

cancer vaccines

Boehringer Ingelheim

Amal Therapeutics

Flag link:

Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up

Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up

Stat

Flag link:

Long-lasting HIV injection is a step closer after second GSK study

Long-lasting HIV injection is a step closer after second GSK study

Reuters

Flag link:

FDA says it will consider approval of first dengue vaccine, despite controversy

FDA says it will consider approval of first dengue vaccine, despite controversy

Stat

Flag link:

'Unprecedented' demand for Merck's Gardasil drives monster Q3

'Unprecedented' demand for Merck's Gardasil drives monster Q3

Fierce Pharma

Flag link:

Inovio touts intradermal delivery of HIV vaccine

Inovio touts intradermal delivery of HIV vaccine

Drug Delivery Business News

Flag link:

J&J steps up vaccines R&D—and preps for launches—with €72M plant

J&J steps up vaccines R&D—and preps for launches—with €72M plant

Fierce Pharma

drug manufacturing

Flag link:

Pages